株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

猫アレルギー:パイプライン分析

Cat Allergy - Pipeline Review, H2 2017

発行 Global Markets Direct 商品コード 246030
出版日 ページ情報 英文 26 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.76円で換算しております。
Back to Top
猫アレルギー:パイプライン分析 Cat Allergy - Pipeline Review, H2 2017
出版日: 2017年08月22日 ページ情報: 英文 26 Pages
概要

猫アレルギーは、猫が作り出すアレルゲンに対して起こるアレルギー反応です。症状にはくしゃみや鼻水、鼻づまり、鼻づまりが原因の顔面痛、咳、胸部圧迫感、息切れ、喘鳴、涙目、目の充血やかゆみ、発疹、じんましんなどがあります。

当レポートでは、猫アレルギーの治療薬開発パイプラインの現況と最新アップデートによる各開発段階の比較分析、企業や研究機関によって開発中の治療薬、治療薬の評価、後期段階および中止されたプロジェクトに関する情報などを最新のニュースや発表も交えて提供しています。

イントロダクション

  • 調査範囲

猫アレルギー 概要

治療薬の開発

  • パイプライン製品;概要

企業で開発中の治療薬

パイプライン製品の概況

  • 後期段階の製品
  • 臨床段階の製品
  • 初期段階の製品

企業で開発中の製品

治療薬開発に従事している企業

  • ALK-Abello A/S
  • Amgen Inc.
  • Biomay AG
  • Circassia Pharmaceuticals plc

治療薬の評価

  • 単剤製品
  • 標的別
  • 作用機序別
  • 投与経路別
  • 分子タイプ別

薬剤プロファイル

  • Allergen for Cat Allergy
  • Allergen for Cat Allergy
  • BM-36
  • Epsi-Gam
  • tezepelumab
  • Vaccine for Cat Allergy
  • Vaccine for Cat Allergy

最近のパイプライン動向

休止中のプロジェクト

開発が中止された製品

製品開発のマイルストーン

  • 主なニュースとプレスリリース

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC9640IDB

Summary:

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cat Allergy - Pipeline Review, H2 2017, provides an overview of the Cat Allergy (Immunology) pipeline landscape.

Cat allergy is an allergic reaction to one or more allergens produced by cats. Symptoms include sneezing, runny or stuffy nose, facial pain (from nasal congestion), coughing, chest tightness, shortness of breath and wheezing, watery, red or itchy eyes and skin rash or hives.

Report Highlights:

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Cat Allergy - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Cat Allergy (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Cat Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Cat Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Preclinical and Discovery stages are 1, 2 and 2 respectively.

Cat Allergy (Immunology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Cat Allergy (Immunology).
  • The pipeline guide reviews pipeline therapeutics for Cat Allergy (Immunology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Cat Allergy (Immunology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Cat Allergy (Immunology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Cat Allergy (Immunology)

Reasons to buy:

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Cat Allergy (Immunology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Cat Allergy (Immunology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Global Markets Direct Report Coverage
  • Cat Allergy - Overview
    • Cat Allergy - Therapeutics Development
    • Pipeline Overview
    • Pipeline by Companies
    • Products under Development by Companies
  • Cat Allergy - Therapeutics Assessment
    • Assessment by Target
    • Assessment by Mechanism of Action
    • Assessment by Route of Administration
    • Assessment by Molecule Type
  • Cat Allergy - Companies Involved in Therapeutics Development
    • ALK-Abello A/S
    • Amgen Inc
    • Biomay AG
  • Cat Allergy - Drug Profiles
    • Allergen for Cat Allergy - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Allergen for Cat Allergy - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Allergen for Cat Allergy - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • BM-36 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • tezepelumab - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
  • Cat Allergy - Dormant Projects
  • Cat Allergy - Discontinued Products
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
  • Disclaimer

List of Tables

  • Number of Products under Development for Cat Allergy, H2 2017
  • Number of Products under Development by Companies, H2 2017
  • Products under Development by Companies, H2 2017
  • Number of Products by Stage and Target, H2 2017
  • Number of Products by Stage and Mechanism of Action, H2 2017
  • Number of Products by Stage and Route of Administration, H2 2017
  • Number of Products by Stage and Molecule Type, H2 2017
  • Cat Allergy - Pipeline by ALK-Abello A/S, H2 2017
  • Cat Allergy - Pipeline by Amgen Inc, H2 2017
  • Cat Allergy - Pipeline by Biomay AG, H2 2017
  • Cat Allergy - Dormant Projects, H2 2017
  • Cat Allergy - Discontinued Products, H2 2017

List of Figures

  • Number of Products under Development for Cat Allergy, H2 2017
  • Number of Products under Development by Companies, H2 2017
  • Number of Products by Routes of Administration, H2 2017
  • Number of Products by Stage and Routes of Administration, H2 2017
  • Number of Products by Molecule Types, H2 2017
  • Number of Products by Stage and Molecule Types, H2 2017
Back to Top